The pharmaceutical companies are always in a hurry to get new vaccinations on the market. With the recent heavy push being the HPV vaccination, Ardabil, for young girls. Parents are being told that their daughters can eliminate certain cervical cancer risks if they get vaccinated at an early age. What they aren’t telling you are that there are severe side effects born from this vaccination. Young girls have died from this vaccine and others have suffered adverse side effects such as blood clots and even Gullian-Barre Syndrome, which is a devastating nerve disorder that paralyzes a person and may take years to recover physically, and possibly a lifetime to overcome psychologically. At the Potts Law firm our Ardabil injury attorneys are working just as aggressively to make sure that the young girls’ lives that have been affected are taken care of. If your daughter has experienced any side effects after her vaccination with Ardabil or if your daughter died because of it; we want to help your family and especially your daughter gets the compensation she deserves after having to endure a life changing event, which was brought on by something that was supposed to help her. Unfortunately, vaccines are often put on the market without knowing what all the side effects are and the general population pays the price for it. The pharmaceutical companies need to be held accountable for the irreversible damage both physically and emotionally that they create. If your daughter was one of the many that suffered ill effects because of this vaccination, contact us today for a free consultation. Fighting large corporations and pharmaceutical companies is not a battle to enter into without experience on your side. With a broad range of expertise and proven trial lawyers, the Potts Law Firm specializes in pharmaceutical and medical device litigation, catastrophic injury, and product liability. We are here to help when you need it most. Contact us today at 1-888-99-POTTS (1-888-997-6887) for a free consultation.
Please Rate this Article 5 out of 54 out of 53 out of 52 out of 51 out of 5
Not yet Rated
